2006
DOI: 10.1016/j.cbi.2006.01.002
|View full text |Cite
|
Sign up to set email alerts
|

Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K–Akt pathways

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
75
1

Year Published

2008
2008
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 113 publications
(81 citation statements)
references
References 34 publications
5
75
1
Order By: Relevance
“…Activation of PI3K-Akt and ERK pathways has been suggested to be critical for cell motility stimulated by HGF [30,31,37] …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Activation of PI3K-Akt and ERK pathways has been suggested to be critical for cell motility stimulated by HGF [30,31,37] …”
Section: Discussionmentioning
confidence: 99%
“…It has been suggested that HGF induces cell invasion of HepG2 cells via the ERK pathway and phosphatidylinositol 3-kinase (PI3K)-Akt pathway [30,31]. VPA (2 mM), however, did not show any significant effect on phosphorylation of ERK and Akt or nuclear translocation of phosphorylated ERK in the cells treated for 15, 30 and 60 min with HGF (10 ng/ml) (data not shown).…”
Section: Hgf-induced Invasion Of Hepg2 Cells (Data Not Shown)mentioning
confidence: 92%
“…The ability of cancers to metastasize is directly associated with cell adhesion and invasion (Lee et al 2006). Adhesive ability of metastatic tumor cells is a critical factor in extravasations and formation of new tumor foci.…”
Section: Pl Suppresses Adhesive and Invasive Behavior Of Hepg2 Cellsmentioning
confidence: 99%
“…The anticancer effect of Lu also is associated with inducing apoptosis, which involves redox regulation, DNA damage, and protein kinases in inhibiting the proliferation of cancer cells and suppressing metastasis and angiogenesis. 6,[10][11][12][13][14][15][16][17] Moreover, Lu has cytotoxicity in cancer cells or immortalized cells, but not in normal cells, meaning that it has fewer side effects when used in treating cancer. 8,12,18 Yet Lu has some drawbacks, such as poor water solubility (,2 × 10 −2 µmol/mL), 19 low oral absorption, 20 and bioavailability (30.4% in rats), 21 which limit its clinical application.…”
Section: Introductionmentioning
confidence: 99%